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The function of holocytochrome c synthase (HCCS, also called heme lyase) is to attach covalently the
heme cofactor to cytochromes c in the mitochondria of animals, fungi and protozoa. Little is known
about how the protein functions but CP motifs, commonly found in heme-binding proteins, are
present. Here we examine holocytochrome c production by Saccharomyces cerevisiae HCCS in the
Escherichia coli cytoplasm with emphasis on the conserved CPmotifs long implicated in heme trans-
fer by this enzyme. Unexpectedly, the two motifs, both towards the N-terminus, were not required
for activity. Mutations in HCCS on the C-terminal side of the CPmotifs, known to cause disease states
in humans (microphthalmia with linear skin defects) abolished or drastically attenuated holocyto-
chrome c production.
 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction import. As part of the regulation of heme biosynthesis, d-aminolev-The biosynthesis of cytochrome c is a catalysed post-transla-
tional modiﬁcation performed by one of several known protein
systems that vary between organisms [1–3]. Holocytochrome c is
produced when two thioether bonds are formed between the thiols
of two cysteines in a characteristic CXXCH motif in the apocyto-
chrome and the vinyl groups of heme. In animal, fungal and proto-
zoan mitochondria cytochrome c production relies on the protein
holocytochrome c synthase, HCCS (also called heme lyase). HCCS
has a well documented role in the import of the apocytochrome
into the mitochondrion [4,5], but its role in the covalent attach-
ment reaction of heme to the protein is poorly understood.
A heme-binding role for HCCS might be expected as heme is one
of the two substrates. Such binding has been suggested in a study
indicating heme binding to a CPV motif in Saccharomyces cerevisiae
HCC1S [6], the protein required for heme attachment to cytochrome
c1 in fungi. CP sequences have been described as heme-regulatory
motifs (HRM) inavarietyofproteins. Bybinding toaHRM,hemereg-
ulates the activity of transcription factors (for example, in the tran-
scriptional repressor Bach1 [7]) as well as mitochondrial proteinchemical Societies. Published by E
; HCC1S, holocytochrome c1
ophthalmia with linear skin
.
. Stevens), stuart.ferguson@ulinate synthase import into themitochondrion is inhibitedbyheme
[8]. Direct binding of the heme by the cysteines in these motifs has
been indicated; heme-binding studies with HRM peptides have
shown that the cysteines are essential for interaction with heme
[9]. Replacement of the proline in themotif also appeared to change
the afﬁnity of heme binding [9]. Mutations in the HCCS gene, else-
where than in the sequences coding for CPmotifs, have been identi-
ﬁed in patients suffering fromMLS (microphthalmiawith linear skin
defects), a condition causing abnormal development of the eyes and
skin [10]. The amino acid replacements are thought to affect cyto-
chrome c production such that apoptosis signalling is altered; cyto-
chrome c release from the mitochondrion is key to initiating
apoptosis [11]. The CP motifs and the amino acids associated with
MLS are shown in the sequence alignment of HCCS proteins from a
range of organisms in Fig. 1. Residues replaced in this work are
highlighted.
Here we utilise an assay system for HCCS by coexpression of the
protein with a cytochrome c, from a single plasmid, in the Esche-
richia coli cytoplasm [12]. The advantage of this approach, over
studying HCCS activity in yeast, is that the combination of HCCS
functions, including apocytochrome c import, heme acquisition
and thioether bond formation, can be separated. In the mitochon-
drial intermembrane space heme has to be imported from the ma-
trix, where it is synthesised, and apocytochrome polypeptides have
to be imported from the cytosol. In E. coli the situation is simpliﬁed
as all components are produced in the same compartment, allow-
ing a focussing on the heme attachment reaction.lsevier B.V. All rights reserved.
Fig. 1. Multiple sequence alignment of holocytochrome c synthase proteins. Amino
acids replaced in this work are underlined, highlighted and in bold. Sc is S. cerevisiae
GI number 595545; Nc is Neurospora Crassa GI number 168804; Ca is Candida
albicans GI number 1438967; Hs is Homo sapiens GI number 285002259; Mm isMus
musculus GI number 225543251; Ce is Caenorhabditis elegans GI number 3879529.
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2.1. Plasmids and strains
Mutationswere introducedby site-directedmutagenesis into the
S. cerevisiae holocytochrome c synthase gene in the plasmid pWT
cytochrome c [12], producing plasmids pRM01-09. Quikchange
PCR mutagenesis (Stratagene) with KOD DNA polymerase (Strata-
gene) was used. A plasmid expressing a His-tagged form of HCCS
(pRM15) was produced by insertional mutagenesis introducing
codons for 6 C-terminal histidine residues into the HCCS genein pWT cytochrome c. The MLS mutations were also performed
in pRM15 producing pRM17-20. The plasmids are listed in
Table 1; all DNA constructs were sequenced before use
(Geneservice, Oxford). E. coli strain DH5a was used for routine
DNA manipulations. The activity assays were performed in E. coli
strain BL21(DE3).
2.2. Culture conditions and bacterial fractionation
HCCS activity was determined in the E. coli cytoplasm using a
plasmid that coexpresses the S. cerevisiae HCCS (and variants)
and Equus caballus cytochrome c [12], transformed into E. coli
BL21(DE3). Bacteria were cultured in Luria Bertani medium sup-
plemented with 100 lg/ml ampicillin and grown for 18–20 h at
37 C. For some variants small scale cultures were sufﬁcient for
analysis; 20 ml cultures in a 50 ml tube were inoculated directly
with single colonies from agar plates. When more cell extracts
were required for analysis, 1 l cultures in 2 l ﬂasks were inoculated
with 2 ml of overnight cultures and grown for 18 h at 37 C with
shaking at 200 rpm. All cultures were harvested and the periplas-
mic fractions removed; spheroplasts were produced as described
[13]. The periplasms were removed because of the possibility of
endogenous heme-containing proteins in this compartment. For
the small scale cultures the cytoplasmic extracts were prepared
using BugBuster (Novagen), followed by centrifugation (according
to the manufacturer’s instructions). For the large scale cultures
cytoplasmic extracts were produced by sonicating the sphero-
plasts, followed by centrifugation at 16000g at 4 C for 20 min.
2.3. Analysis of holocytochrome c content
Cytoplasmic extracts were analysed by SDS–PAGE on precast
10% Nu–PAGE gels (Invitrogen). The gels were stained for proteins
containing covalently attached heme according to the method of
Goodhew [14]. UV–visible spectroscopy was performed on a Perkin
Elmer UV–visible spectrophotometer Lambda 2 instrument. Ex-
tracts were reduced by the addition of a few grains of sodium
dithionite. Pyridine hemochrome spectra were obtained following
treatment of the extracts with 19% (vol/vol) pyridine in 0.15 M
NaOH. Results were normalised according the mass of the wet cell
pellet after harvesting. At least six replicates were performed for
each experiment. Quantitations were performed by measuring
absorbances of cytoplasmic extracts at 550 nm (with baseline cor-
rection for extracts of cells not expressing a cytochrome) following
reduction. Standard deviations were calculated for these values
and are shown in the bar charts. The SDS–PAGE gels show a repre-
sentative extract for each variant.
2.4. Western blots
HCCS protein expression was examined by performing Western
blots following SDS–PAGE analysis of cytoplasmic extracts
expressing pRM15 and the 4 MLS variants. A penta-His antibody
(Qiagen) was used as the primary antibody and the secondary anti-
body was anti-mouse alkaline phosphatase-conjugated antibody
(Sigma). Detection was performed using SIGMAFAST BCIP/NBT tab-
lets (Sigma) according to the manufacturer’s instructions.3. Results
3.1. Functional importance of the CP motifs in S. cerevisiae
holocytochrome c synthase
In order to study the function of the CP motifs, mutations were
introduced into both CP motifs present in S. cerevisiae HCCS
Table 1
Plasmids used in this study.
Plasmid Relevant properties Reference
pWTcytochrome c S. cerevisiae HCCS and horse cytochrome c,
AmpR
[12]
pRM01 pWTcytochrome c with HCCS C26A mutation This work
pRM02 pWTcytochrome c with HCCS C42A mutation This work
pRM03 pWTcytochrome c with HCCS C26AP27A
mutation
This work
pRM04 pWTcytochrome c with HCCS C42AP43A
mutation
This work
pRM05 pWTcytochrome c with HCCS C26AC42A
mutation
This work
pRM06 pWTcytochrome c with HCCS E133A
mutation
This work
pRM07 pWTcytochrome c with HCCS E133K
mutation
This work
pRM08 pWTcytochrome c with HCCS R199A
mutation
This work
pRM09 pWTcytochrome c with HCCS R199C
mutation
This work
pRM15 pWTcytochrome c with an C-terminal
His6-tag on HCCS
This work
pRM17 pRM15 with HCCS E133A mutation This work
pRM18 pRM15 with HCCS E133K mutation This work
pRM19 pRM15 with HCCS R199A mutation This work
pRM20 pRM15 with HCCS R199C mutation This work
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been shown to be essential for heme binding in HRMs in other pro-
teins, the two single-cysteine variants were made (C26A and
C42A). Replacement of both C and P with alanine was also done
for both motifs (C26AP27A and C42AP43A). A ﬁfth variant was cre-
ated in which both cysteines were replaced with alanine, in order
to establish whether one motif might be able to compensate for the
absence of the other (C26AC42A). E. coli containing these plasmids
were cultured and the cytoplasmic extracts analysed for holocyto-
chrome c content by SDS–PAGE analysis followed by heme stain-
ing, and UV–vis spectroscopy. The SDS–PAGE gel for one set of
parallel experiments is shown in Fig. 2. A heme-staining band at
the expected molecular mass (12 kDa, compared with the marker
proteins shown) for horse holocytochrome c appears for the wild-
type HCCS (lane 1) and all of the variants tested (lanes 2–6). Lane 7
shows a negative control from cells containing a cytochrome c
plasmid but no HCCS gene.
UV–visible spectroscopy of the cell extracts showed typical
holocytochrome c spectroscopic features for the wild-type and all
variants (Soret band at 415 nm, b at 520 nm, and a at 550 nm).M 1 2 3 4 5 6 7
Fig. 2. Heme-stained SDS-PAGE of cytoplasmic extracts of E. coli expressing wild-
type HCCS and its CP motif variants. The expected mass of horse holo-cytochrome c
is 12 kDa. M = Seeblue Plus 2 protein marker; 1 = wild-type; 2 = C26A; 3 = C42A;
4 = C26AP27A; 5 = C42AP43A; 6 = C26AC42A; 7 = no HCCS. Loading was standard-
ized for wet cell pellet mass. The protein markers, from the bottom, have masses of
6, 14, and 28 kDa.In the presence of pyridine and NaOH the a-bands of the wild-type
and variant proteins were observed at 550 nm, indicating that two
bonds to the heme had been formed in all cases. The position of the
a-band is characteristic of the saturation of the heme vinyl groups
and conﬁrms that two bonds have been formed between the heme
and the cytochrome. The absorbances at 550 nm under reducing
conditions were measured and used to quantitate the holocyto-
chrome c content for each culture. The average values (and stan-
dard deviations, see Section 2) are shown in Fig. 3,
demonstrating comparable levels of holocytochrome produced by
the variant proteins compared with the wild-type. Densitometry
of the heme-stained bands on SDS–PAGE yielded similar results,
but was found to be less reliable for quantitation than spectro-
scopic measurements.
3.2. The importance of HCCS residues implicated in disease states
The amino acids replacements identiﬁed in the HCCS proteins of
patients suffering fromMLS are R217C (the equivalent of R199 in S.
cerevisiae HCCS) and E159K (E133 in yeast). We have mutated the
yeast HCCS gene in our system in order to determine the effect on
activity of these replacements. The clinically observed replace-
ments were performed, as well as changing both E133 and R199
separately to alanine. The cytochrome c content in cultures
expressing these variants was measured as above; the SDS–PAGE
analysis, followed by heme staining, is shown in Fig. 4A. A small
amount of holocytochrome c was detected with the E133A variant
(lane 2), compared with the wild-type level seen in lane 1. For the
other variants only traces of holocytochrome were detected by
heme staining (lanes 3–5). Lane 6 contains cytoplasmic extract of
cells containing no plasmids. UV–visible spectroscopy conﬁrmed
the attenuation/abolition of holocytochrome c production for the
MLS variants, and was used for quantitation, as shown in Fig. 5.
Fig. 4B shows by Western blotting that wild-type HCCS and the
four MLS variant proteins were expressed; a C-terminal His-tag
was incorporated for immunodetection. A negative control (con-
taining no plasmids) is shown in lane 6. The wild-type His-tagged
protein was found to catalyse formation of holocytochrome c at
similar levels to the untagged protein, thus establishing that the
His-tag did not interfere with activity of HCCS. These observations
add to the earlier evidence that the variant HCCS proteins are not
intrinsically unstable because studies in mitochondria by others
have shown successful targeting of the same variants to the inter-
membrane space [10,15].
4. Discussion
4.1. The role of the CP motifs in HCCS
CP motifs have been shown in numerous proteins to bind heme
for a variety of regulatory purposes. HRMs function in regulating0.3
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Fig. 3. Quantitation of cytochrome c levels produced by HCCS and CP motif
variants. Absorbances of cytoplasmic extracts at 550 nm were measured following
reduction with sodium dithionite. Error bars are indicated (see Section 2).
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Fig. 5. Quantitation of cytochrome c levels produced by HCCS and MLS variants.
Absorbances of cytoplasmic extracts at 550 nm were measured following reduction
with sodium dithionite. Error bars are indicated (see Section 2).
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presence in HCCS proteins has been noted [9]; the motifs have
been shown to be essential for full HCC1S activity in yeast [6].
There are indications, however, that even in mitochondria the per-
turbation of CP motifs attenuates rather than abolishes cytochrome
c formation, suggesting that the motifs are not obligatory [6,18]. In
the mitochondrial intermembrane space the role of this motif
could include heme recruitment before binding as a substrate for
attachment to apocytochrome c, a regulatory role involving heme
sensing, or even a redox role involving cysteine reduction/oxida-
tion. Assaying HCCS in the E. coli cytoplasm allows us to reﬁne
our understanding of this motif. Our results indicate that the CP
motifs are not required for the HCCS function of heme attachment
to apocytochromes c. Replacement of the cysteines, along with the
adjacent prolines, and even replacement of both motifs did not sig-
niﬁcantly affect the activity.
4.2. MLS variants
The two amino acid substitutions known to occur in patients
suffering from MLS have been examined in yeast [10,15] where
they were found to be unable to complement for respiratory
growth, but were targeted to the IMS. Our HCCS assay system
showed that the clinically observed substitutions resulted in very
low levels of HCCS activity with the E133 variants and levels of
holocytochrome cwith the R199 variants that were not detectable.
Replacement of the two MLS-associated residues with alanine was
also performed because the clinically observed replacements are
more dramatic in terms of the side-chain properties. The change
in charge in the E133K might be expected to have a more signiﬁ-
cant effect than an alanine replacement. The R199C mutation
introduces the potential complications of thiol chemistry, poten-
tially causing the formation of non-native disulﬁde bonds, or even
acting as a competing ligand to the heme iron. The alanine replace-
ments made little difference compared to the clinically observed
substitutions, indicating that E133 and R199 are functionally
important.
5. Conclusion
The focus on the CP motifs in HCCS proteins dates back to a time
when relatively few sequences were available. Now that many
more sequences have been determined it is clear that whereas
CP motifs are almost ubiquitous, their number varies from 0 (very
rarely) to 5 and they are located in the relatively non-conservedM 1 2 3 4 5 6
A
B
Fig. 4. (A) Heme-stained SDS-PAGE of cytoplasmic extracts of E. coli expressing
wild-type HCCS and its MLS variants. The protein markers, from the bottom, have
masses of 6 and 14 kDa. The expected mass of horse holo-cytochrome c is 12 kDa.
(B) Western blot of cytoplasmic extracts of E. coli expressing wild-type HCCS and its
MLS variants. An anti-penta-His antibody was used to detect His-tagged HCCS.
M = Seeblue Plus 2 protein marker; 1 = wild-type; 2 = E133A; 3 = E133K; 4 = R199A;
5 = R199C and 6 = extract from cells containing no plasmids. The marker band has a
mass of 38 kDa. The HCCS has an expected mass of 31 kDa. Loading was
standardized for wet cell pellet mass.N-terminal region of the protein (Fig. 1). The conserved region of
the protein is towards the C-terminus and the importance of this
region to HCCS function is reﬂected by the deleterious effects of
the mutations associated with the MLS disease, as demonstrated
here. The present ﬁndings do not mean that the CP motifs have
no function. It is possible, for example, that they are involved in
recruiting heme in the IMS in mitochondria. A heme acquisition
role would be consistent with previous studies indicating heme
binding to the CP motifs and the results shown here, that is the
heme attachment reaction can occur in the absence of CP motifs
in a compartment where heme is synthesised (the E. coli cyto-
plasm) and readily available. The advantage of studying HCCS in
E. coli is that any such function can be separated from the process
that is directly involved in attachment of heme to apocytochrome
c. The region of HCCS responsible for heme attachment remains to
be identiﬁed but the CP motifs do not appear to be involved.
Note added in proof
What is known about HCCS has just been reviewed [19] and two
recent studies concern substrate recognition and speciﬁcity prop-
erties of HCCS [20,21].
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